June 1, 2011 ā Real-time polymerase chain reaction (PCR) assays of both liquid- and dried-saliva specimens are highly sensitive and specific for detecting cytomegalovirus (CMV) and should be ...
When we found out we were expecting our third child, we were overjoyed. No pregnancy is easy, of course, and we already had our hands full with two little ones. But this was our third time around, and ...
COBAS AmpliPrep/COBAS TaqMan CMV Test Kit by Roche Roche announced that it has received approval from the FDA for COBAS AmpliPrep/COBAS TaqMan CMV Test, a new test to assess a patient's viral load of ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first in vitro diagnostic test used to monitor cytomegalovirus treatment in hematopoietic ...
First FDA-approved laboratory test for quantifying DNA of potentially deadly virus helps physicians manage organ transplant patients on antiviral therapy "With this new test, diagnostic laboratories ...
(Reuters) Jun 05 - U.S. health regulators on Thursday approved a first-of-its-kind DNA test by Swiss drugmaker Roche Holding AG to help physicians track progress in treating organ transplant patients ...
- CMV is the most common and serious viral infection in transplant patients - The cobas® CMV test provides reliable, reproducible, high-quality results for clinical decision-making - CMV viral load ...
The U.S.Food and Drug Administration has approved a DNA test to ascertain how transplant patients respond to treatment for cytomegalovirus or CMV, according to an FDA statement, to improve ...
The heel-stick procedure, a routine screening test for several metabolic and genetic disorders in newborns, is not effective in screening for cytomegalovirus (CMV) infection, a leading cause of ...
Increasing numbers of patients are undergoing allogeneic bone marrow transplantation for haematological malignancies and other conditions. While antibacterial and antifungal prophylaxis and therapy ...
COBAS AmpliPrep/COBAS TaqMan CMV Test Kit by Roche Roche announced the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Roche announced the commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results